[1]
Seyam, M.S. et al. 2015. Evaluation of fluvastatin in combination with the standard of care therapy (PEG-IFN/Ribavirin) in Egyptian patients with hepatitis C virus. Turkish Journal of Gastroenterology. 26, 6 (Jan. 2015), 511–516. DOI:https://doi.org/10.5152/tjg.2015.15806.